May 2022 in “International Journal of Dermatology” A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.
A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.
December 2021 in “Turkderm” The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.
November 2021 in “Open Forum Infectious Diseases” Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.
July 2021 in “International journal of innovative research in medical science” Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.
Topical Minoxidil is effective for hair loss after COVID-19.
March 2021 in “Clinical Medicine” A team of different healthcare experts is good for treating long-term COVID-19 issues.
January 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)” The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.
October 2021 in “Journal of Investigative Dermatology” No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.
April 2023 in “Journal of Investigative Dermatology” COVID-toes show a unique immune response over time, different from vaccine-related chilblains.
91 citations,
July 2020 in “JAMA Dermatology” Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.
71 citations,
April 2020 in “Journal of Cosmetic Dermatology” Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
42 citations,
June 2020 in “Seminars in Oncology” Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.
41 citations,
February 2021 in “Cureus” Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.
31 citations,
August 2020 in “EClinicalMedicine” Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.
24 citations,
June 2020 in “Journal of the American Academy of Dermatology” Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.
21 citations,
November 2021 in “Journal of the European Academy of Dermatology and Venereology” The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.
12 citations,
April 2020 in “Medical hypotheses” Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.
8 citations,
September 2020 in “Journal of adolescent health” Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.
7 citations,
December 2021 in “Journal of Infection” One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.
7 citations,
July 2020 in “Dermatologic Therapy” During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.
6 citations,
December 2023 in “Lancet. Infectious diseases/The Lancet. Infectious diseases” SIM01 significantly reduced post-COVID symptoms and is safe.
6 citations,
October 2020 in “Journal of the European Academy of Dermatology and Venereology” Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.
6 citations,
October 2020 in “medRxiv (Cold Spring Harbor Laboratory)” Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.
5 citations,
May 2021 in “Journal of Cosmetic Dermatology” More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.
5 citations,
May 2020 in “Journal of The American Academy of Dermatology” Hydroxychloroquine might help prevent COVID-19, but more research is needed.
4 citations,
May 2021 in “medRxiv (Cold Spring Harbor Laboratory)” Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.
3 citations,
August 2021 in “Clinical, Cosmetic and Investigational Dermatology” Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.